Price T Rowe Associates Inc Legend Biotech Corp Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,808,081 shares of LEGN stock, worth $250 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,808,081
Previous 11,165,584
39.03%
Holding current value
$250 Million
Previous $544 Million
59.28%
% of portfolio
0.03%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$276 Million3.96% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$220 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$210 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$210 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$128 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.15B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...